Vector-host-pathogen interface in monocytotropic ehrlichiosis

单核埃利希体病中的载体-宿主-病原体界面

基本信息

  • 批准号:
    8392057
  • 负责人:
  • 金额:
    $ 22.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ehrlichioses are emerging life-threatening diseases transmitted by ticks in humans and animals worldwide. Although mechanisms of systemic immunity and immunopathogenesis to needle inoculated disseminated ehrlichiosis have been characterized, the early events in the cutaneous tick transmission site and draining lymph nodes have not been investigated. The role of the vector in pathogen transmission and modulation of the host response requires an animal model of tick transmission to determine the mechanisms of establishment of infection. Under some condition tick saliva causes an imbalance of cytokine regulation, and also suppresses host innate and adaptive immunity by inhibiting antigen presentation, effector cell migration, and microbicidal mechanisms. These disturbances of the host response create an environment for pathogens to establish infection. The long term goal of this project is to determine the role of the vector-host-pathogen interactions on the establishment of ehrlichial infection and the mechanisms of ehrlichial evasion of host defenses. The objective of this application is to characterize a tick transmission model and identify the early events of the immune response to the tick-transmitted ehrlichiae. Our central hypothesis is that tick saliva modulates the local host immune response facilitating establishment of ehrlichial infection. To test our hypothesis we will: (1) Characterize vector transmission of monocytotropic ehrlichiosis. Working hypothesis: The life cycle of ehrlichiae within the vector is initiated in th midgut followed by ehrlichial migration to the salivary glands, where the bacteria replicate during transmission; and (2) characterize the primary immune response to ehrlichial infection transmitted by tick feeding compared to needle inoculation. Working hypothesis: Establishment of ehrlichial infection is favored by modulation of innate immunity by tick saliva leading to ehrlichial entry into APCs (DCs and macrophages) and dissemination by evading the host defenses. We expect to understand the earliest events in the host immune response (innate immunity) and disease establishment in monocytotropic ehrlichiosis, as well as the host-vector-pathogen interface. PUBLIC HEALTH RELEVANCE: This project addresses an important issue regarding ehrlichioses, which are tick transmitted diseases, by study of the developmental cycle and migration of the pathogen within the vector during transmission and the events in the host skin. In thick-borne diseases the role of the vector on the establishment of infection has been studied for only a single pathogen, Borrelia, but no studies have been performed for other agents. This proposal will examine the migration dynamics and multiplication of ehrlichia in the tick organs during transmission and correlate these early events with the host innate immune response.
描述(由申请方提供):埃立克体病是一种由蜱传播的威胁生命的疾病,在全球范围内传播给人类和动物。虽然全身免疫和免疫发病机制针接种播散性埃立克体病的特点,在皮肤蜱传播网站和引流淋巴结的早期事件尚未进行研究。媒介在病原体传播和调节宿主反应中的作用需要蜱传播的动物模型来确定感染建立的机制。在某些情况下,蜱唾液引起细胞因子调节的失衡,并且还通过抑制抗原呈递、效应细胞迁移和杀微生物机制来抑制宿主的先天性和获得性免疫。这些宿主反应的干扰为病原体建立感染创造了环境。本项目的长期目标是确定媒介-宿主-病原体相互作用在埃立克体感染建立中的作用以及埃立克体逃避宿主防御的机制。本申请的目的是表征蜱传播模型并识别对蜱传播的埃立克体的免疫应答的早期事件。我们的中心假设是,蜱唾液调节局部宿主免疫反应,促进埃立克体感染的建立。为了验证我们的假设,我们将:(1)描述单嗜性埃里希体病的媒介传播。工作假设:载体内埃里希体的生命周期始于中肠,随后埃里希体迁移到唾液腺,在唾液腺中细菌在体内复制。 传播;和(2)表征与针接种相比,对通过蜱饲养传播的埃立克体感染的初级免疫应答。工作假设:通过蜱唾液调节先天免疫,导致埃立克体进入APC(DC和巨噬细胞)并通过逃避宿主防御而传播,从而有利于埃立克体感染的建立。我们期望了解宿主免疫反应(先天免疫)和单核细胞埃立克体病疾病建立的最早期事件,以及宿主-载体-病原体界面。 公共卫生相关性:该项目通过研究传播过程中媒介内病原体的发育周期和迁移以及宿主皮肤中的事件,解决了关于埃立克体病(蜱传播疾病)的重要问题。在厚传播疾病中,仅针对单一病原体疏螺旋体研究了载体对建立感染的作用,但尚未针对其他病原体进行研究。本研究将探讨埃立克体在传播过程中在蜱器官中的迁移动力学和增殖,并将这些早期事件与宿主的先天免疫反应联系起来。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID H WALKER其他文献

DAVID H WALKER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID H WALKER', 18)}}的其他基金

Developmental Research Plan
发展研究计划
  • 批准号:
    8377041
  • 财政年份:
    2012
  • 资助金额:
    $ 22.95万
  • 项目类别:
Career Development and Training Program
职业发展和培训计划
  • 批准号:
    8377034
  • 财政年份:
    2012
  • 资助金额:
    $ 22.95万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8377037
  • 财政年份:
    2012
  • 资助金额:
    $ 22.95万
  • 项目类别:
Vector-host-pathogen interface in monocytotropic ehrlichiosis
单核埃利希体病中的载体-宿主-病原体界面
  • 批准号:
    8495268
  • 财政年份:
    2012
  • 资助金额:
    $ 22.95万
  • 项目类别:
Developmental Research Plan
发展研究计划
  • 批准号:
    8233011
  • 财政年份:
    2011
  • 资助金额:
    $ 22.95万
  • 项目类别:
Career Development and Training Program
职业发展和培训计划
  • 批准号:
    8233007
  • 财政年份:
    2011
  • 资助金额:
    $ 22.95万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8233008
  • 财政年份:
    2011
  • 资助金额:
    $ 22.95万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    8042570
  • 财政年份:
    2010
  • 资助金额:
    $ 22.95万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7676462
  • 财政年份:
    2009
  • 资助金额:
    $ 22.95万
  • 项目类别:
Developmental Research Plan
发展研究计划
  • 批准号:
    7676511
  • 财政年份:
    2009
  • 资助金额:
    $ 22.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 22.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了